secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2024-04-15T23:59:59+00:00
Accession:  0001837607-24-000026
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AEON Biopharma sets warrant redemption FMV at $7.6994, cashless ratio 0.2456
----------------------------------------------------------------------------

- Redemption Fair Market Value calculated at $7.6994 per Public Warrant under Warrant Agreement Section 6.2.
- Cashless exercise yields approximately 0.2456 shares of common stock per Public Warrant.
- Redemption date remains April 29, 2024; unexercised warrants void and holders receive $0.10 each.
- Supplemental notice follows initial redemption announcement on March 29, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000183760724000026/0001837607-24-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000183760724000026/aeon-20240415x8k.htm
  HTML page:      https://secwatch.observer/filing/0001837607-24-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer